Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Work In Process (2016 - 2025)

Fresenius Medical Care AG has reported Work In Process over the past 17 years, most recently at $171.0 million for Q4 2025.

  • Quarterly results put Work In Process at $171.0 million for Q4 2025, up 28.92% from a year ago — trailing twelve months through Dec 2025 was $171.0 million (up 28.92% YoY), and the annual figure for FY2025 was $171.0 million, up 28.92%.
  • Work In Process for Q4 2025 was $171.0 million at Fresenius Medical Care AG, up from $132.6 million in the prior quarter.
  • Over the last five years, Work In Process for FMCQF hit a ceiling of $171.0 million in Q4 2025 and a floor of $120.4 million in Q4 2021.
  • Median Work In Process over the past 5 years was $132.6 million (2024), compared with a mean of $138.9 million.
  • Biggest five-year swings in Work In Process: dropped 7.57% in 2024 and later increased 28.92% in 2025.
  • Fresenius Medical Care AG's Work In Process stood at $120.4 million in 2021, then grew by 5.4% to $126.9 million in 2022, then grew by 13.04% to $143.5 million in 2023, then decreased by 7.57% to $132.6 million in 2024, then increased by 28.92% to $171.0 million in 2025.
  • The last three reported values for Work In Process were $171.0 million (Q4 2025), $132.6 million (Q4 2024), and $143.5 million (Q4 2023) per Business Quant data.